WealthTrust Fairport’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$52K Hold
598
﹤0.01% 235
2018
Q4
$46K Hold
598
﹤0.01% 231
2018
Q3
$46K Hold
598
﹤0.01% 257
2018
Q2
$40K Sell
598
-207
-26% -$14.3K ﹤0.01% 265
2018
Q1
$58K Buy
+805
New +$61.3K 0.01% 222
2015
Q1
Sell
-598
Closed -$50K 303
2014
Q4
$50K Sell
598
-112
-16% -$9.28K 0.01% 176
2014
Q3
$60K Hold
710
0.01% 150
2014
Q2
$58K Hold
710
0.01% 155
2014
Q1
$54K Hold
710
0.01% 149
2013
Q4
$51K Sell
710
-23
-3% -$1.6K 0.01% 141
2013
Q3
$50K Sell
733
-144
-16% -$9.53K 0.01% 162
2013
Q2
$56K Buy
+877
New +$57.1K 0.01% 158

Other funds holding NVS

WealthTrust Fairport's NVS Position: Q1 2019 in Review

WealthTrust Fairport held its Novartis (NVS) position steady in Q1 2019 at 598 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

WealthTrust Fairport first reported a position in NVS in Q2 2013 and has held it in 12 quarters since. The position peaked at $60K in Q3 2014. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

  • WealthTrust Fairport held 598 shares of Novartis worth $52K as of Q1 2019.
  • WealthTrust Fairport left its Novartis share count unchanged in Q1 2019.
  • Novartis made up ﹤0.01% of WealthTrust Fairport's portfolio in Q1 2019, its #235 holding.
  • WealthTrust Fairport first reported a position in Novartis in Q2 2013 and has held it in 12 quarters since.
  • WealthTrust Fairport's Novartis position peaked at $60K in Q3 2014.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.